Tonix Pharmaceuticals Files 8-K
Ticker: TNXP · Form: 8-K · Filed: Apr 25, 2025 · CIK: 1430306
Sentiment: neutral
Topics: 8-K, financial-condition, operations
Related Tickers: TNXP
TL;DR
Tonix Pharma dropped an 8-K on 4/25 - check financials and other events.
AI Summary
Tonix Pharmaceuticals Holding Corp. filed an 8-K on April 25, 2025, reporting on its results of operations and other events. The filing details the company's financial condition and significant corporate activities.
Why It Matters
This filing provides an update on Tonix Pharmaceuticals' operational and financial status, which is crucial for investors to assess the company's performance and future prospects.
Risk Assessment
Risk Level: medium — 8-K filings can contain significant news that impacts a company's stock price, requiring careful review.
Key Players & Entities
- Tonix Pharmaceuticals Holding Corp. (company) — Registrant
- April 25, 2025 (date) — Date of earliest event reported
- Nevada (jurisdiction) — State of Incorporation
- 26 Main Street, Chatham, New Jersey 07928 (address) — Principal executive offices
- (862) 904-8182 (phone_number) — Registrant's telephone number
FAQ
What is the primary purpose of this 8-K filing?
This 8-K filing is to report on Tonix Pharmaceuticals Holding Corp.'s results of operations and financial condition, as well as other events.
On what date was the earliest event reported in this filing?
The earliest event reported in this filing was on April 25, 2025.
In which U.S. state is Tonix Pharmaceuticals Holding Corp. incorporated?
Tonix Pharmaceuticals Holding Corp. is incorporated in Nevada.
What is the principal executive office address for Tonix Pharmaceuticals Holding Corp.?
The principal executive office address is 26 Main Street, Chatham, New Jersey 07928.
What is the telephone number provided for Tonix Pharmaceuticals Holding Corp.?
The telephone number provided for Tonix Pharmaceuticals Holding Corp. is (862) 904-8182.
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on April 25, 2025 regarding Tonix Pharmaceuticals Holding Corp. (TNXP).